Related Experiment Video
Updated: Jul 22, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
The molecular genetics of Marfan syndrome and related disorders
P N Robinson1, E Arteaga-Solis, C Baldock
1Institute of Medical Genetics, Charité University Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany. peter.robinson@charite.de
Abstract:
Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated individuals with MFS is acute aortic dissection, which often follows a period of progressive dilatation of the ascending aorta. Recent research on the molecular physiology of fibrillin and the pathophysiology of MFS and related disorders has changed our understanding of this disorder by demonstrating changes in growth factor signalling and in matrix-cell interactions. The purpose of this review is to provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils. Mutations in FBN1 and other genes found in MFS and related disorders will be discussed, and novel concepts concerning the complex and multiple mechanisms of the pathogenesis of MFS will be explained.
Insights
Marfan syndrome (MFS) is a genetic connective tissue disorder caused by FBN1 gene mutations. Understanding fibrillin
Area of Science:
- Genetics
- Molecular Biology
- Connective Tissue Disorders
Background:
- Marfan syndrome (MFS) is an autosomal dominant hereditary disorder affecting skeletal, ocular, and cardiovascular systems.
- Mutations in the fibrillin-1 (FBN1) gene are the primary cause of MFS.
- Acute aortic dissection, often following aortic dilatation, is the leading cause of premature death in untreated MFS patients.
Purpose of the Study:
- To provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils.
- To discuss mutations in FBN1 and other genes associated with MFS and related disorders.
- To explain novel concepts regarding the complex pathogenesis of MFS.
Main Methods:
- Review of recent research on molecular physiology of fibrillin.
- Analysis of pathophysiology of MFS and related disorders.
- Discussion of genetic mutations and their impact on disease mechanisms.
Main Results:
- Recent research has elucidated changes in growth factor signaling and matrix-cell interactions in MFS.
- Understanding of MFS pathophysiology has evolved through studies on fibrillin's molecular physiology.
- FBN1 mutations and their role in MFS pathogenesis are increasingly understood.
Conclusions:
- Advances in molecular biology have reshaped the understanding of Marfan syndrome.
- Fibrillin-1 and its associated pathways are critical in MFS pathogenesis.
- Further research into genetic mutations and molecular mechanisms is crucial for MFS management.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
06:39Biological Preparation and Mechanical Technique for Determining Viscoelastic Properties of Zonular Fibers
Published on: December 16, 2021
Related Concept Videos
Sex-linked Disorders
Cohesins
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of homologous...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aneurysm I: Introduction